Vericel Corporation announced that it has submitted a Biologics License Application (BLA) to the FDA for MACI (matrix applied characterized...
Vericel Corporation has reported positive results from the three-year extension of the Phase III SUMMIT study with MACI (matrix-applied characterized...
The FDA has approved Maci (autologous cultured chondrocytes on porcine collagen membrane), from Vericel Corporation, for the repair of symptomatic,...
New results show that MACI (matrix-induced autologous chondrocyte implant), from Genzyme/Sanofi, met its co-primary endpoint in a two-year, randomized, controlled...
Aastrom Biosciences, Inc. the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, has...